Decades into its tenure as a drug seller, CSL Behring has finally dipped its toe into the waters of TV advertising. | Decades ...

The acquisition will strengthen BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701, which is currently being assessed for the treatment of ...

The BLU-U Model 4170E offers a compact, easy-to-use option with the same BLU-U safety and efficacy healthcare professionals have trusted for years. The new LED BLU-U is approved for the same ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the-counter pain reliever: Tylenol. Researchers developed trehalose ...

"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis," said Abhay ...

Conestoga Capital Advisors, LLC claims compliance with the Global Investment Performance Standards (GIPS) and has prepared and presented this report in compliance with the GIPS standards ...

Melbourne Pharma Logo Redefining modern healthcare for Gen Z Melbourne Pharma is redefining healthcare for Gen Z in Florida with personalized compounded medications for skincare, mental health, hormon ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Visit a quote page and your recently viewed tickers will be displayed here.

More Bonds of BridgeBio Pharma Inc. About the BridgeBio Pharma Inc.-Bond (US10806XAH52) The BridgeBio Pharma Inc.-Bond has a maturity date of 3/1/2031 and offers a coupon of 1.7500%. The payment ...